Cardio3 BioSciences,a Belgian developer of cell-based therapies for the treatment of cardiovascular diseases,has raised €7.2 million in Series B funding.Backers include Hunza Ventures,Life Science Research Partners and Grifols.In conjunction with the Series B funding,Cardio3 also secured €6.5 mi [...]